EF
AVNS

Empowered Funds’s Avanos Medical AVNS Stock Holding History

Empowered Funds’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-175,069
Closed -$2.45M – 2128
2026
Q1 		$2.45M Sell
175,069
-39,293
-18% -$529K 0.02% 994
2025
Q4 		$2.41M Buy
214,362
+20,807
+11% +$238K 0.04% 434
2025
Q3 		$2.24M Buy
193,555
+22,367
+13% +$262K 0.02% 863
2025
Q2 		$2.1M Buy
171,188
+9,006
+6% +$113K 0.02% 799
2025
Q1 		$2.32M Buy
162,182
+8,348
+5% +$130K 0.03% 679
2024
Q4 		$2.45M Buy
153,834
+90,091
+141% +$1.78M 0.04% 644
2024
Q3 		$1.53M Sell
63,743
-127,491
-67% -$2.91M 0.02% 766
2024
Q2 		$3.81M Buy
191,234
+13,680
+8% +$266K 0.07% 401
2024
Q1 		$3.54M Buy
177,554
+13,409
+8% +$259K 0.06% 418
2023
Q4 		$3.68M Buy
164,145
+14,784
+10% +$305K 0.09% 310
2023
Q3 		$3.02M Buy
149,361
+12,166
+9% +$276K 0.09% 307
2023
Q2 		$3.51M Buy
+137,195
New +$3.61M 0.12% 210

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.72B AUM 70.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Empowered Funds's AVNS Position: Q2 2026 in Review

Empowered Funds sold out of Avanos Medical (AVNS) in Q2 2026, closing a stake of 175,069 shares — an estimated $2.45M sold.

Empowered Funds first reported a position in AVNS in Q2 2023 and held it in 12 quarters. The position peaked at $3.81M in Q2 2024. 286 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • Empowered Funds reported no remaining Avanos Medical position as of Q2 2026 after selling out during the quarter.
  • Empowered Funds sold 175,069 Avanos Medical shares in Q2 2026, an estimated $2.45M.
  • Empowered Funds first reported a position in Avanos Medical in Q2 2023 and held it in 12 quarters.
  • Empowered Funds's Avanos Medical position peaked at $3.81M in Q2 2024.
  • 286 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.